Skip to main content
PMC home page
Journal of the National Medical Association logoLink to Journal of the National Medical Association
. 1992 Apr;84(4):315–319.

Autism and developmental abnormalities in children with perinatal cocaine exposure.

E Davis 1, I Fennoy 1, D Laraque 1, N Kanem 1, G Brown 1, J Mitchell 1
PMCID: PMC2637680  PMID: 1380564

Abstract

Cocaine in all forms is the number one illicit drug of choice among pregnant women. Records of 70 children with cocaine exposure in utero who were referred for developmental evaluation at a large inner-city hospital were reviewed in an effort to determine whether a specific pattern of abnormalities could be discerned. Patients received physical examinations, neurological screenings, and behavioral and developmental assessments based on the Gesell Developmental Inventory, and the Denver Developmental Screening Test. Documentation of specified drug use was obtained by history. Mean age (SEM) at referral was 19.2 (1.7) months. All mothers used cocaine in one of its forms, although polydrug use was common. Growth parameters were low (median = 15th percentile). Significant neurodevelopmental abnormalities were observed, including language delay in 94% of the children and an extremely high frequency of autism (11.4%). The high rate of autistic disorders not known to occur in children exposed to alcohol or opiates alone suggests specific cocaine effects.

Full text

PDF
315

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boyer C. S., Petersen D. R. Potentiation of cocaine-mediated hepatotoxicity by acute and chronic ethanol. Alcohol Clin Exp Res. 1990 Feb;14(1):28–31. doi: 10.1111/j.1530-0277.1990.tb00441.x. [DOI] [PubMed] [Google Scholar]
  2. Chasnoff I. J., Burns W. J., Schnoll S. H., Burns K. A. Cocaine use in pregnancy. N Engl J Med. 1985 Sep 12;313(11):666–669. doi: 10.1056/NEJM198509123131105. [DOI] [PubMed] [Google Scholar]
  3. Chasnoff I. J. Drug use and women: establishing a standard of care. Ann N Y Acad Sci. 1989;562:208–210. doi: 10.1111/j.1749-6632.1989.tb21019.x. [DOI] [PubMed] [Google Scholar]
  4. Cherukuri R., Minkoff H., Feldman J., Parekh A., Glass L. A cohort study of alkaloidal cocaine ("crack") in pregnancy. Obstet Gynecol. 1988 Aug;72(2):147–151. [PubMed] [Google Scholar]
  5. Dixon S. D., Bejar R. Echoencephalographic findings in neonates associated with maternal cocaine and methamphetamine use: incidence and clinical correlates. J Pediatr. 1989 Nov;115(5 Pt 1):770–778. doi: 10.1016/s0022-3476(89)80661-4. [DOI] [PubMed] [Google Scholar]
  6. Doberczak T. M., Shanzer S., Senie R. T., Kandall S. R. Neonatal neurologic and electroencephalographic effects of intrauterine cocaine exposure. J Pediatr. 1988 Aug;113(2):354–358. doi: 10.1016/s0022-3476(88)80283-x. [DOI] [PubMed] [Google Scholar]
  7. Foltin R. W., Fischman M. W. Ethanol and cocaine interactions in humans: cardiovascular consequences. Pharmacol Biochem Behav. 1988 Dec;31(4):877–883. doi: 10.1016/0091-3057(88)90399-1. [DOI] [PubMed] [Google Scholar]
  8. LeBlanc P. E., Parekh A. J., Naso B., Glass L. Effects of intrauterine exposure to alkaloidal cocaine ('crack') Am J Dis Child. 1987 Sep;141(9):937–938. doi: 10.1001/archpedi.1987.04460090014001. [DOI] [PubMed] [Google Scholar]
  9. MacGregor S. N., Keith L. G., Chasnoff I. J., Rosner M. A., Chisum G. M., Shaw P., Minogue J. P. Cocaine use during pregnancy: adverse perinatal outcome. Am J Obstet Gynecol. 1987 Sep;157(3):686–690. doi: 10.1016/s0002-9378(87)80029-7. [DOI] [PubMed] [Google Scholar]
  10. Oro A. S., Dixon S. D. Perinatal cocaine and methamphetamine exposure: maternal and neonatal correlates. J Pediatr. 1987 Oct;111(4):571–578. doi: 10.1016/s0022-3476(87)80125-7. [DOI] [PubMed] [Google Scholar]
  11. Ritvo E. R., Jorde L. B., Mason-Brothers A., Freeman B. J., Pingree C., Jones M. B., McMahon W. M., Petersen P. B., Jenson W. R., Mo A. The UCLA-University of Utah epidemiologic survey of autism: recurrence risk estimates and genetic counseling. Am J Psychiatry. 1989 Aug;146(8):1032–1036. doi: 10.1176/ajp.146.8.1032. [DOI] [PubMed] [Google Scholar]
  12. Vadlamani N. L., Pontani R. B., Misra A. L. Effect of diamorphine, delta 9-tetrahydrocannabinol and ethanol on intravenous cocaine disposition. J Pharm Pharmacol. 1984 Aug;36(8):552–554. doi: 10.1111/j.2042-7158.1984.tb04452.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES